Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
-
Published:2023-10-01
Issue:10
Volume:30
Page:1461-1470
-
ISSN:1340-3478
-
Container-title:Journal of Atherosclerosis and Thrombosis
-
language:en
-
Short-container-title:JAT
Author:
Tobita Kazuki1, Takahara Mitsuyoshi2, Iida Osamu3, Soga Yoshimitsu4, Yamaoka Terutoshi5, Ichihashi Shigeo5, Saito Shigeru1
Affiliation:
1. Department of Cardiology, Shonan Kamakura General Hospital 2. Department of Diabetes Care Medicine and Department of Metabolic Medicine, Osaka University Graduate School of Medicine 3. Cardiovascular Center, Kansai Rosai Hospital 4. Department of Cardiology, Kokura Memorial Hospital 5. Department of Vascular Surgery, Matsuyama Red Cross Hospital
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine
Reference17 articles.
1. 1) Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Rother J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I and Group ESCSD: 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018; 39: 763-816 2. 2) Bailey SR, Beckman JA, Dao TD, Misra S, Sobieszczyk PS, White CJ, Wann LS, Bailey SR, Dao T, Aronow HD, Fazel R, Gornik HL, Gray BH, Halperin JL, Hirsch AT, Jaff MR, Krishnamurthy V, Parikh SA, Reed AB, Shamoun F, Shugart RE and Yucel EK: ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine. Journal of the American College of Cardiology, 2019; 73: 214-237 3. 3) Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ, Parikh SA, Prasad A, Rosenfield K, Shishehbor MH, Swaminathan RV and White CJ: SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv, 2018; 92: 124-140 4. 4) Ohki T, Kichikawa K, Yokoi H, Uematsu M, Yamaoka T, Maeda K and Kanaoka Y: Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions. J Vasc Surg, 2017; 66: 130-142 e131 5. 5) Iida O, Takahara M, Soga Y, Yamaoka T, Nanto S, Kuratani T, Sakata Y and Mano T: One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study. J Endovasc Ther, 2021; 28: 123-131
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|